rs35159397
Positions:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 2P and 17B. PM2BP4_StrongBP6_Very_StrongBP7BS1
The NM_152618.3(BBS12):c.105A>T(p.Ser35=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00027 in 1,613,498 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0014 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00015 ( 0 hom. )
Consequence
BBS12
NM_152618.3 synonymous
NM_152618.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0300
Genes affected
BBS12 (HGNC:26648): (Bardet-Biedl syndrome 12) The protein encoded by this gene is part of a complex that is involved in membrane trafficking. The encoded protein is a molecular chaperone that aids in protein folding upon ATP hydrolysis. This protein also plays a role in adipocyte differentiation. Defects in this gene are a cause of Bardet-Biedl syndrome type 12. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 4-122741997-A-T is Benign according to our data. Variant chr4-122741997-A-T is described in ClinVar as [Benign]. Clinvar id is 531843.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-122741997-A-T is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-0.03 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00144 (219/152348) while in subpopulation AFR AF= 0.00481 (200/41586). AF 95% confidence interval is 0.00426. There are 0 homozygotes in gnomad4. There are 105 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
BBS12 | NM_152618.3 | c.105A>T | p.Ser35= | synonymous_variant | 2/2 | ENST00000314218.8 | |
BBS12 | NM_001178007.2 | c.105A>T | p.Ser35= | synonymous_variant | 3/3 | ||
BBS12 | XM_011531680.3 | c.105A>T | p.Ser35= | synonymous_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
BBS12 | ENST00000314218.8 | c.105A>T | p.Ser35= | synonymous_variant | 2/2 | 1 | NM_152618.3 | P1 | |
BBS12 | ENST00000542236.5 | c.105A>T | p.Ser35= | synonymous_variant | 3/3 | 2 | P1 | ||
BBS12 | ENST00000433287.1 | c.105A>T | p.Ser35= | synonymous_variant | 3/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00144 AC: 219AN: 152230Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
219
AN:
152230
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000442 AC: 111AN: 251138Hom.: 0 AF XY: 0.000346 AC XY: 47AN XY: 135734
GnomAD3 exomes
AF:
AC:
111
AN:
251138
Hom.:
AF XY:
AC XY:
47
AN XY:
135734
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000148 AC: 216AN: 1461150Hom.: 0 Cov.: 31 AF XY: 0.000125 AC XY: 91AN XY: 726780
GnomAD4 exome
AF:
AC:
216
AN:
1461150
Hom.:
Cov.:
31
AF XY:
AC XY:
91
AN XY:
726780
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00144 AC: 219AN: 152348Hom.: 0 Cov.: 33 AF XY: 0.00141 AC XY: 105AN XY: 74510
GnomAD4 genome
AF:
AC:
219
AN:
152348
Hom.:
Cov.:
33
AF XY:
AC XY:
105
AN XY:
74510
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Mar 29, 2021 | - - |
Bardet-Biedl syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at